may first think nothing clinical psychology psychiatry let keep mind says lot fda oversight capabilities pharmagossip link excerpt david graham editorial latest jama graham one meaning approximately two people fda stepped plate discuss risks certain medications like cox inhibitors antidepressants especially cox recently reported meta analysis randomized trials covering nsaids kearney et al found trials rofecoxib mg acute mi risk increased rr ci compared placebo celecoxib trials rr ci driven studies doses mg higher combined vascular event risk primarily mi compared placebo also increased diclofenac rr ci approached statistical significance ibuprofen rr ci risk increased naproxen rr ci mean first rofecoxib increases risk acute mi low high doses risk begins early therapy probably first dose initial month period immunity risk celecoxib also increases risk doses higher mg lower doses potential risk less clear several nsaids increase risk including cox selective nsaids diclofenac meloxicam nonselective nsaid indomethacin probably ibuprofen meta analyses randomized clinical trials observational studies agree naproxen neutral mi risk pharmagossip better quote graham i wo steal i encourage check link graham editorial